OppenheimerFunds’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$213K Sell
4,067
-11,977
-75% -$627K ﹤0.01% 1693
2018
Q4
$848K Buy
16,044
+12,806
+395% +$732K ﹤0.01% 1120
2018
Q3
$205K Sell
3,238
-480
-13% -$31.1K ﹤0.01% 1780
2018
Q2
$217K Sell
3,718
-414
-10% -$22.4K ﹤0.01% 1744
2018
Q1
$212K Sell
4,132
-203,366
-98% -$10.9M ﹤0.01% 1723
2017
Q4
$12.4M Buy
207,498
+3,920
+2% +$238K 0.01% 713
2017
Q3
$12M Buy
+203,578
New +$12.1M 0.01% 714
2017
Q1
Sell
-938,658
Closed -$42M 1906
2016
Q4
$42M Sell
938,658
-1,780,724
-65% -$78.9M 0.05% 366
2016
Q3
$129M Buy
2,719,382
+375,730
+16% +$19.4M 0.16% 163
2016
Q2
$130M Buy
2,343,652
+1,616,922
+222% +$77.9M 0.17% 151
2016
Q1
$33.2M Buy
+726,730
New +$27.8M 0.04% 417

Other funds holding CONE

OppenheimerFunds's CONE Position: Q1 2019 in Review

OppenheimerFunds reduced its CyrusOne Inc Common Stock (CONE) stake by 75% in Q1 2019, selling an estimated $627K and leaving 4,067 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #1693.

OppenheimerFunds first reported a position in CONE in Q1 2016 and has held it in 11 quarters since. The position peaked at $130M in Q2 2016. 377 funds tracked by Wall St. Rank hold CONE as of Q1 2019.

  • OppenheimerFunds held 4,067 shares of CyrusOne Inc Common Stock worth $213K as of Q1 2019.
  • OppenheimerFunds sold 11,977 CyrusOne Inc Common Stock shares in Q1 2019, an estimated $627K.
  • CyrusOne Inc Common Stock made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1693 holding.
  • OppenheimerFunds first reported a position in CyrusOne Inc Common Stock in Q1 2016 and has held it in 11 quarters since.
  • OppenheimerFunds's CyrusOne Inc Common Stock position peaked at $130M in Q2 2016.
  • 377 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.